Tuberculosis (TB) remains one of the world's deadliest diseases. Increasing rates of drug-resistant tuberculosis in Eastern Europe, Asia and sub-Saharan Africa now threaten to undermine the gains made by worldwide tuberculosis control efforts. The region of Macedonia in North Greece is an entrance gate of thousands of immigrants, moving mainly from East European countries with high tuberculosis prevalence to Greece and the whole Europe. Our study determines the drug susceptibility pattern of new TB cases in the region of Macedonia, Greece. A total of 63 M. tuberculosis strains were isolated by cultivation between January 2012 and December 2014 in Macedonia, North Greece. After microscopic examination with Ziehl-Neelsen staining, clinical samples were simultaneously tested by two methods: conventional culture method on the Löwenstein-Jensen (L-J) slants for 8 weeks (at 370˚C) and molecular method Genotype MTBDR plus (Hain-Lifescience). According to the study results, 2 out of 63 strains (3.2%) were resistant to both isoniazid (INH) and rifampicin (RMP). Additionally, 3 strains (4.8%) were INH mono-resistant. Statistical analysis demonstrated that there was no statistically significant difference in presence of resistance according to patients' gender or origin (Greeks or immigrants). It is clear that the implementation of an efficient nationwide system for the surveillance, diagnosis and treatment of TB is essential. The best strategy in order to control, and prevent TB includes, first of, all a rapid diagnosis and initiation of treatment, something which is the most important for public health.
Introduction
Tuberculosis (TB) remains one of the most devastating and widespread infections in the world [1] [2] . In 2014, an estimated 9.6 million people developed TB and 1.5 million died from the disease, 392,000 of whom were human immunosuppressive virus (HIV) positive. It is estimated that 66 million lives were saved between 1995 and 2014, through effective diagnosis and treatment. However, given that most deaths from TB are preventable, the death toll from the disease is still unacceptable high [3] . In Greece, the case notification rate was 4.7 cases per 100,000 inhabitants in 2012, while less than 50% of all reported TB cases were confirmed by bacterial culture [4] . Moreover, underreporting is an important issue for TB control in Greece (it is estimated 77% -81%). Various limitations in the national TB monitoring system exist, many of them due to the economic crisis. There are also access limitations [5] - [7] . Furthermore, migration from regions with high TB incidence (for example, Former Soviet Union countries-FSU) possibly leads to further underestimation of the TB burden and facilitates further spread of the disease. Reluctance to notify TB cases and failure to collect data at regional and national level makes TB surveillance and trend analysis problematic [8] . It is also noteworthy that the percentage of cases due to resistant strains is increasing worldwide, according to World Health Organization (WHO) [9] . It is estimated that, on a global level, 3.7% of TB treatment-new cases and 20% (13% -26%) of previously treated TB cases have multidrug-resistant TB (MDR-TB) i.e. resistant to both isoniazid (INH) and (RMP). By 2015, 105 countries had reported cases of extensively drug resistant TB (XDR-TB), including 13 countries and territories that had reported more than ten XDR-TB cases in a single year. The average percentage of XDR-TB cases was 9.6% (95% CI: 8.1% -11%) [10] . In Greece, resistance ratio is also increasing and MDR-TB represents 3%, 4% of TB cases in Greeks (lower than the EU average 4%, 6%) and 25% in foreign born patients [8] . In our region there is access to TB diagnosis, through the free national healthcare system. There were no national guidelines for TB-management before 2014. The aim of the present study is to determine the drug susceptibility pattern of new TB cases in the region of Macedonia.
Material and Method
Our study was a cross-sectional study of new TB cases, aged >18 years. A total of 63 M. tuberculosis strains were isolated by cultivation between January 2012 and December 2014 in Macedonia, North Greece. Our samples were collected from the "G. Papanikolaou" Hospital in Thessaloniki which is the major hospital for TB management in Macedonia region, Greece. The strains were selected from symptomatic patients with a diagnosis of pulmonary and extra-pulmonary tuberculosis. No ethical approval was required for this study. After microscopic examination with Ziehl-Neelsen staining, clinical samples were simultaneously tested by two methods: conventional culture method on the Löwenstein-Jensen (L-J) slants for 8 weeks (at 37˚C) and molecular method Genotype MTBDR plus (Hain-Lifesciene). The cultures were subjected to phenotypic identification based on growth and colony characteristics, pigment production and bi- 1.865, p = 0.172, Fisher's exact test 0.166). Age did not significantly differ according to presence of resistance. Both MDR-TB strains were isolated from patients who were male, aged 64 and 26 years old respectively. The 64-year-old patient was a Greek patient, under chemotherapy due to stomach cancer, while the younger one was an immigrant from Ukraine.
Discussion and Conclusion
Despite the remarkable efforts to control TB, the disease remains one of the most serious infectious diseases, with incalculable financial impact on health care system of the country. Moreover, important issues regarding drug resistance have emerged. According to the present study, 3.2% of the isolated strains were MDR-TB, while 4.8% of them were INH mono-resistant. Resistance to first-line anti-TB drugs remains higher in Greece than in most other countries in Western Europe [11] . On the other hand, much higher INH resistance rates were observed in FSU countries, for example Kazakhstan, Latvia, Russia, Georgia, Estonia and Lithuania. Moreover, MDR-TB was also much higher in the above FSU countries as well, than in Greece (3.2%) and the rest of Europe (median European MDR rate 1.0%) [12] . Multi-drug resistant TB is more prevalent in Greece, in comparison with other Western European countries. This is likely the result of immigration, late diagnosis and inadequate treatment of index cases within Greece. Although the statistical analysis of the results of the present study demonstrated that there were no statistically significant associations between patients' origin and drugresistance, previous and current data confirm that the absolute number of resistant cases in immigrants still appears to be increasing [8] [13] . Another study that was conducted in N. Greece, during 2007-2010, demonstrates that TB cases among immigrants tend to increase, contributing significantly to overall higher incidence rates. Additionally, immigrants also tend to present with more severe disease and emerge more frequent relapses and higher prevalence of resistant and MDR-TB [14] . there is still a long way to go [19] . The best strategy in order to control and prevent TB includes, first of all, a rapid diagnosis and initiation of treatment, something which is the very important for public health.
